28 th Annual Scientific Meeting
|
|
- Stewart Grant
- 5 years ago
- Views:
Transcription
1 Value for money in oncology research 28 th Annual Scientific Meeting March 2016 Brisbane Convention & Exhibition Centre Please note this is a Preliminary Program and is subject to changes. Updates will be made as topics, presentations and presenters are confirmed. 1 TROG 2016 ASM Preliminary Program_website version_ docx
2 Tuesday 15 March am 10.30am Opening Session Boulevard Auditorium am Convenor Welcome am Welcome to Country am Official Welcome am President s Report am TSC Update am TCOO Update am am International Guest Speaker: Dr Tito Fojo M.D., Ph.D. The Current Oncology Fantasy: Personalised/Precision Medicine National Guest Speaker: Professor Marion Haas Health Economics am Boulevard Foyer Morning Tea 11.00am 1.00pm Breast SubSpecialty Group Session Boulevard - B1 Chair: Peter Graham am Welcome am am am 11.55am pm pm National Guest Speaker: Dr Nicole Haynes Harnessing the therapeutic potential of radiation therapy with antibody-based immunotherapeutic strategies New trial proposal presentation Category B Randomised phase III trial of adjuvant radiotherapy versus observation following breast conserving surgery and endocrine therapy in patients with molecularly characterized low-risk luminal A early breast cancer Local HER-0: A phase II pilot study of local therapy only (stereotactic radiosurgery and or surgery) for treatment of up to 5 brain metastases from HER2+ breast cancer. HART: Deep Inhalation Breath Hold radiotherapy for patients with left sided breast cancer (STARS): A randomised comparison of anastrozole commenced before and continued during adjuvant radiotherapy for breast cancer versus anastrozole and subsequent antioestrogen therapy delayed until after radiotherapy. 2 TROG 2016 ASM Preliminary Program_website version_ docx
3 pm pm pm pm (PET-LABRADOR): Pet scans for Locally Advanced Breast cancer and diagnostic MRI to determine the extent of Operation and Radiotherapy (DCIS): A randomised phase III study of radiation doses and fractionation schedules for ductal carcinoma in situ (DCIS) of the breast (SUPREMO): A phase III randomised trial to assess the role of adjuvant chest wall irradiation in 'intermediate risk' operable breast cancer following mastectomy. SUPREMO (Selective Use of Postoperative Radiotherapy after MastectOmy) BIG (APBI): A Multicentre Feasibility Study of Accelerated Partial Breast Irradiation Using Three-Dimensional Conformal Radiation Therapy for Early Breast pm (RAPID): Randomized trial of accelerated partial breast irradiation pm Discussion 11.00am 1.00pm Genito-Urinary SubSpecialty Group Session Boulevard - B2 Co-Chairs: David Pryor / Shankar Siva am Welcome am am pm pm pm pm pm New trial proposal: FASTRACK II (Category A) Focal Ablative Stereotactic Radiosurgery for Cancers of the Kidney, a Phase II Clinical Trial. CORE: A multistage multicentre international randomised trial of Conventional care Or Radioablation (stereotactic body radiotherapy) for Extra-cranial oligometastatic disease (CORE) in lung, breast and prostate cancer (RAIDER): A randomised phase II trial of adaptive image guided standard or dose escalated radiotherapy in the treatment of transitional cell carcinoma of the bladder (SPARK): Stereotactic Prostate Adaptive Radiotherapy utilising KIM (Kilovoltage Intrafraction Monitoring) / ANZUP1303 (ENZARAD): Randomised phase 3 trial of radiation plus androgen deprivation therapy with or without enzalutamide for high risk, clinically localised, prostate cancer (RAVES): A phase III multi-centre randomised trial comparing adjuvant radiotherapy (RT) with early salvage RT in patients with positive margins or extraprostatic disease following radical prostatectomy. PSMA-PET directed Oligometastatic Prostate cancer treated with Stereotactic Ablative Radiotherapy to Nodes. (Trial in Development) pm Discussion 11.00am 1.00pm Head & Neck and Skin SubSpecialty Groups Session Boulevard Auditorium Co-Chairs: Chris Wratten 11am 12.15pm June Corry 12.25pm 1pm am Welcome 3 TROG 2016 ASM Preliminary Program_website version_ docx
4 am 11.55am 12.05pm pm pm pm pm pm pm National Guest Speaker: Professor Peter Hersey Challenges for radiotherapy in the anti PD1/PD-L1 era (MP3): A phase II efficacy study of chemo-radiotherapy in PET stage II and III Merkel cell carcinoma of the skin (RTN2): A randomised trial of post operative radiation therapy following wide excision of neurotropic melanoma of the head and neck (WBRT): Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma-a randomised phase III trial (POST): Post operative concurrent chemo-radiotherapy versus post-operative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck (EORTC1219): A blind randomized multicentre study of accelerated fractionated chemoradiotherapy with or without the hypoxic cell radiosensitizer nimorazole (Nimoral), using a 15- gene signature for hypoxia in the treatment of HPV/p16 negative squamous cell carcinoma of the head and neck (EAT): Eating As Treatment (EAT): An RCT of psychological training for dieticians to reduce malnutrition and depression in head and neck cancer patients undergoing radiotherapy (HPV Oropharynx): A randomised trial of weekly cetuximab and radiation versus weekly cisplatin and radiation in good prognosis locoregionally advanced HPV-associated oropharyngeal squamous cell carcinoma am 1.00pm Lung SubSpecialty Group Session Boulevard B3 Co-Chairs: Fiona Hegi Johnson / David Ball am Welcome am am :50am 11.50am 12.00pm pm pm pm International Guest Speaker: Professor Dirk De Ruysscher Radiotherapy and immune therapy: Good partners? SABR-OS: A phase II randomized trial to test the feasibility of randomizing patients with peripheral stage I non-small cell lung cancer (NSCLC) to either Stereotactic Ablative Radiotherapy (SABR) Or Surgery NivoRAD: Nivolumab vs nivolumab/rt in NSCLC: Randomised phase 2 trial of nivolumab and radiotherapy versus nivolumab alone in advanced non-small cell lung cancer progressing after first line chemotherapy (SAFRON II): Stereotactic Ablative Fractionated Radiotherapy versus radiosurgery for Oligometastatic Neoplasia to the lung: A randomised Phase II trial (PLUNG_GP): Randomised Phase III trial of high dose palliative radiotherapy (HDPRT) vs Concurrent chemotherapy plus HDPRT (C-HDPRT) in good performance status patient with locally advanced or small volume metastatic NSCLC not suitable for radical chemoradiotherapy (CHISEL): A Randomised Phase III trial of highly conformal hypofractionated image guided ( stereotactic ) radiotherapy (hyport) versus conventionally fractionated radiotherapy (conrt) for inoperable early stage I non-small cell lung cancer. National Guest Speaker: Associate Professor Nick Pavlakis Targeted systemic therapies in lung cancer - relevance to radiotherapy pm Discussion: Review of current portfolio 4 TROG 2016 ASM Preliminary Program_website version_ docx
5 pm Lunch Boulevard Foyer pm Afternoon Breast SubSpecialty Group Session Boulevard B1 Chair: Boon Chua pm National Guest Speaker: Professor Sunil Lakhani Review of established and emerging biomarkers in breast cancer pm Discussion: Horizon scanning / New research directions, opportunities and challenges pm Afternoon Genito-Urinary SubSpecialty Group Session Boulevard B2 Co-Chairs: David Pryor / Shankar Siva pm National Guest Speaker: Paul Thomas PSMA PET trials in prostate cancer and renal cell carcinoma pm Human tissues as a focus for GU radiobiology research pm Discussion: Horizon scanning pm Afternoon Head & Neck and Skin SubSpecialty Groups Session Boulevard Auditorium Chair: Chris Wratten pm Interactive session: Horizon Scanning Holes in the portfolio Other Collaborations Where to next pm Afternoon Lung SubSpecialty Group Session Boulevard B3 Chair: Fiona Hegi Johnson pm pm pm New Proposal: DESSERT (Category A) Decision Support Systems for Radiation Therapy in Non-Small Cell Lung Cancer. HALT: Targeted Therapy beyond Progression with or without Dose-intensified RadiotHerapy for Oligo-Progressive Disease in Oncogene-Addicted Lung Tumours. (New Trial Discussion) Discussion: Plugging gaps in the portfolio - Horizon Scanning - Collaboration pm Afternoon Tea Boulevard Foyer 5 TROG 2016 ASM Preliminary Program_website version_ docx
6 Boulevard Auditorium 3.10pm 5.00pm Session Chair: Farshad Foroudi pm (MA.20): A Phase III study of regional radiation therapy in early breast cancer pm National Guest Speaker: Richard De Abreu Lourenço Using health economics in radiotherapy research pm RANZAR: Registry of Australian and New Zealand Ablative Radiotherapy pm pm pm pm pm pm (ROAM): Radiation versus Observation following surgical resection of Atypical Meningioma: a randomised controlled trial (TOPGEAR): A randomised Phase II/III trial of preoperative Chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer (SCORAD III): A Randomised Phase III study of single fraction radiotherapy compared to multi-fraction radiotherapy in patients with metastatic spinal cord compression (Oesophagus (Dysphagia)): A randomised phase III study in advanced oesophageal carcinoma to compare dysphagia in patients treated with radiotherapy versus chemoradiotherapy (Cervical (FIGO Stage & Tumour Volume)): Prospective Study to Determine the Relationships Between Survival and FIGO Stage, Tumour Volume and Corpus Invasion in Cervical Cancer Primary chemotherapy with temozolomide vs. radiotherapy in patients with low grade gliomas after stratification for genetic 1p loss: a phase III study pm Welcome Dinner - Sponsored by Brainlab Gallery Of Modern Art - Roof Terrace 6 TROG 2016 ASM Preliminary Program_website version_ docx
7 Wednesday 16 March am Breakfast session - Sponsored by Varian Boulevard B1 Boulevard Auditorium 9.00am 9.10am 9.10am 9.20am 9.20am 9.30am 9.30am 9.40am 9.40am 9.50am 9.50am 10.00am 10.00am 10.15am New Proposals Session - Chair: David Christie New Proposal: FASTRACK II (Category A) Focal Ablative Stereotactic Radiosurgery for Cancers of the Kidney, a Phase II Clinical Trial. Discussant 10 mins New Proposal: DESSERT (Category A) Decision Support Systems for Radiation Therapy in Non-Small Cell Lung Cancer. Discussant 10 mins New Proposal: A randomised phase III trial of adjuvant radiotherapy versus observation following breast conserving surgery and endocrine therapy in patients with molecularly characterised low-risk luminal A early breast cancer (Category B) New Proposal: (PLATO)/Anal Cancer Trial 5 (ACT5) PersonaLising Anal cancer RadioTherapy dose (Category B) VESPA - Dosimetric audits for TROG IMRT and VMAT trials using EPID 10.15am 10.25am DATA Mining 10.25am 10.30am Media Matters Promoting your research am Morning Tea Boulevard Foyer am International Guest Speaker: Dr Tito Fojo M.D., Ph.D. Recurrent problems with the design and interpretation of oncology clinical trials 11.45am 1.00pm Annual General Meeting Boulevard Auditorium 1.00pm 1.30pm Lunch Boulevard Foyer 1.30pm 4.30pm Social Afternoon - Afternoon tea at the Convention Centre or the Botanical Gardens 7.00pm 11.00pm Gala Dinner - Sponsored by Elekta Boulevard Room 7 TROG 2016 ASM Preliminary Program_website version_ docx
8 Thursday 17 March am Breakfast session - Sponsored by GenesisCare Boulevard B1 9.00am 1.05pm Boulevard Auditorium - Subspecialty Groups Feedback Sessions Breast SubSpecialty Group Feedback Session - Chair: Verity Ahern am Summary of the TROG portfolio of Breast Studies am Summary of new trial proposals and recommendations of the group am Strategic direction of the group Genito-Urinary SubSpecialty Group Feedback Session - Co-Chairs: David Pryor / Shankar Siva am am GU Session Summary: New trial proposals In development Future directions (TOAD): A collaborative randomized phase III trial: The timing of intervention with androgen deprivation in prostate cancer patients with a rising PSA (Closed) Update - Landmark results am Morning Tea Boulevard Foyer Head & Neck and Skin SubSpecialty Groups Feedback Sessions Co-Chairs: June Corry / Chris Wratten am am Head and Neck Session Summary: Issues with current trials Where to next? Skin Session Summary: Issues with current trials Where to next? Lung SubSpecialty Group Feedback Session - Chair: Fiona Hegi Johnson 11.45am 12.10pm pm Lung Session Summary: new trial proposals and the group s recommendations Issues with current trials Where to next International Guest Speaker: Prof Dirk De Ruysscher Individualized radiotherapy: How biology, physics and genetics meet Closing session pm International Guest Speaker: Dr Tito Fojo A fair price for cancer drugs can be achieved but only if we resolve to make tough decisions 8 TROG 2016 ASM Preliminary Program_website version_ docx
9 pm Close of 2016 ASM Introduction of 2017 ASM Convenor and venue 1.05pm 1.30pm Lunch Boulevard Foyer pm TSC Meeting - by invitation only ASM Additional Meetings Information Monday 14 March TROG-FRO Trainee Statistics & Research Workshop from 8.30am to 5.00pm Room B1 Clinical Research Workshop from 10.00am to 5.30pm Room B2 Technical Research Workshop from 9.30am to 5.30pm Room B3 Tuesday 15 March FROLIC Meeting from 5pm 5.30pm Room B2 Wednesday 16 March TROG Board Meeting from 7.30 to 8.30am Room B2 (by invitation only) TROG Annual General Meeting from 11.45am to 1pm Boulevard Auditorium TROG Publications Committee Meeting lunch time 1pm 1.30pm B2 Thursday 17 March TROG Scientific Committee Meeting from 1.30pm 3.30pm B2 (by invitation only) 9 TROG 2016 ASM Preliminary Program_website version_ docx
CLINICAL INTERVENTIONAL ONCOLOGY SYMPOSIUM
CLINICAL INTERVENTIONAL ONCOLOGY SYMPOSIUM DAY 1 THURSDAY 14 th MARCH 2019 A FOUNDATION COURSE IN CLINICAL INTERVENTIONAL ONCOLOGY Jim Stynes Room A 13.30 13.35 Welcome Dr Nick Brown 13.35 13.45 INTRODUCTION
More informationwe can defeat cancer 2016 Annual Research Report
we can defeat cancer 2016 Annual Research Report TROG conducts world-class research involving radiotherapy to improve outcomes and quality of life for people affected by cancer. Collaboration: We will
More informationTUESDAY 25 OCTOBER WEDNESDAY 26 OCTOBER. Chairperson: A/Professor Nirmala Pathmanathan
TUESDAY 25 OCTOBER 14:00-17:00 Registrations Open 17:00-19:30 Welcome Reception at the Fairmont Resort Leura WEDNESDAY 26 OCTOBER 07:30-08:45 Registrations Open 08:30-10:30 Plenary Session 1 Grand Ballroom
More informationDEPARTMENT OF ONCOLOGY ELECTIVE
DEPARTMENT OF ONCOLOGY ELECTIVE 2015-2016 www.uwo.ca/oncology Oncology Elective Program Administrator: Ms. Kimberly Trudgeon Room A4-901C (Admin) LHSC London Regional Cancer Centre (Victoria Campus) Phone:
More informationSan Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy
San Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy Kathleen C. Horst, M.D. Assistant Professor Department of Radiation Oncology Stanford University The Optimal SEquencing of Adjuvant Chemotherapy
More informationTrial Portfolio Update
Trial Portfolio Update Annual Scientific Meeting 19-22 March 2018 Contents Breast... 3 Brain & Central Nervous System... 7 Head & Neck and Skin... 9 Gastrointestinal... 13 Gynaecological... 14 Lung...
More informationHead and Neck Cancer Update Sandro V Porceddu
Head and Neck Cancer Update Sandro V Porceddu Director, Radiation Oncology Research Princess Alexandra Hospital, Brisbane Associate Professor, University of Queensland President, Trans Tasman Radiation
More informationNorthern Suburbs Clinic for Lung Cancer (NSCLC): Targeting Lung Cancer
Northern Suburbs Clinic for Lung Cancer (NSCLC): Targeting Lung Cancer Page 1 Phuong Tran (Rad Onc) Lung Cancer Most common cause of cancer related deaths in Australia 19% of all cancer deaths Survival
More informationtogether we can defeat cancer Program The Ongoing Evolution of Collaborative Trials
together we can defeat cancer The Ongoing Evolution of Collaborative Trials Program 27th Annual Scientific Meeting 24th 26th March 2015 Newcastle City Hall, 290 King Street, Newcastle NSW 27th ANNUAL SCIENTIFIC
More informationRadiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging
Radiation and DCIS The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging Einsley-Marie Janowski, MD, PhD Assistant Professor Department of Radiation Oncology
More informationStereotactic Ablative Radiotherapy for Prostate Cancer
Stereotactic Ablative Radiotherapy for Prostate Cancer Laurie Cuttino, MD Associate Professor of Radiation Oncology VCU Massey Cancer Center Director of Radiation Oncology Sarah Cannon Cancer Center at
More information55 th Annual Meeting American Society for Radiation Oncology. Patients: Hope Guide Heal News Briefing
55 th Annual Meeting American Society for Radiation Oncology Patients: Hope Guide Heal News Briefing Sunday, September 22, 2013 4:45 p.m. 5:15 p.m. Colleen A.F. Lawton, MD, FASTRO 2013 ASTRO President
More informationHPV INDUCED OROPHARYNGEAL CARCINOMA radiation-oncologist point of view. Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium
HPV INDUCED OROPHARYNGEAL CARCINOMA radiation-oncologist point of view Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium DISCLOSURE OF INTEREST Nothing to declare HEAD AND NECK CANCER -HPV
More informationUPDATE ON RADIOTHERAPY
1 Miriam Kleiter UPDATE ON RADIOTHERAPY Department for Companion Animals and Horses, Plattform Radiooncology and Nuclear Medicine, University of Veterinary Medicine Vienna Introduction Radiotherapy has
More informationBest of ASTRO 2016 Czech Republic
Best of ASTRO 2016 Czech Republic 20. 3. 2017 Kongresové centrum Kunětická Hora Dříteč 09:30-10:10 Track 1 - Gastrointestinal Renata Soumarova, Ass. Prof. (Oncology Centre Novy Jicin, Agel) Abstract 1:
More informationThe Role of Radiation Therapy in the Treatment of Brain Metastases. Matthew Cavey, M.D.
The Role of Radiation Therapy in the Treatment of Brain Metastases Matthew Cavey, M.D. Objectives Provide information about the prospective trials that are driving the treatment of patients with brain
More informationTuesday 25th October
14.00-1700 Tuesday 25th October Registration Open 17.00-19.30 Welcome Reception Wednesday 26th October 1 In Situ Disease and Screening Current Perspectives on the Classification and Significance of In
More informationRadiotherapy What are our options and what is on the horizon. Dr Kevin So Specialist Radiation Oncologist Epworth Radiation Oncology
Radiotherapy What are our options and what is on the horizon Dr Kevin So Specialist Radiation Oncologist Epworth Radiation Oncology Outline Advances in radiotherapy technique Oligo - disease Advancements
More informationResearch Strategy Committee Mitch Machtay, MD Deputy Group Chair, NRG RSC. NRG Semi-Annual Meeting Sunday, February 9, 2014
Research Strategy Committee Mitch Machtay, MD Deputy Group Chair, NRG RSC NRG Semi-Annual Meeting Sunday, February 9, 2014 The size of the Federal budget is not an appropriate barometer of social conscience
More informationHypofractionated radiation therapy for glioblastoma
Hypofractionated radiation therapy for glioblastoma Luis Souhami, MD, FASTRO Professor McGill University Department of Oncology, Division of Radiation Oncology Montreal Canada McGill University Health
More informationNCIC CLINICAL TRIALS GROUP DATA SAFETY MONITORING COMMITTEE Friday, 1 May 2009 SUMMARY REPORT
NCIC CLINICAL TRIALS GROUP DATA SAFETY MONITORING COMMITTEE Friday, 1 May 2009 SUMMARY REPORT The NCIC CTG DSMC reviewed the following trials with respect to safety, trial conduct, including accrual, and
More informationRADIOTHERAPY IN BREAST CANCER :
RADIOTHERAPY IN BREAST CANCER : PAST, PRESENT, FUTURE Dr Jyotirup Goswami Consultant Radiation Oncologist Narayana Cancer Institute Narayana Superspecialty Hospital Breast cancer is the classic paradigm
More informationCombined modality treatment for N2 disease
Combined modality treatment for N2 disease Dr Clara Chan Consultant in Clinical Oncology 3 rd March 2017 Overview Background The evidence base Systemic treatment Radiotherapy Future directions/clinical
More informationPre- Versus Post-operative Radiotherapy
Postoperative Radiation and Chemoradiation: Indications and Optimization of Practice Dislosures Clinical trial support from Genentech Inc. Sue S. Yom, MD, PhD Associate Professor UCSF Radiation Oncology
More informationTuesday 25th October
14.00-1700 Tuesday 25th October Registration Open Welcome reception Wednesday 26th October 1 - In Situ Disease and Screening Current perspectives on the classification and significance of in situ carcinoma
More informationRadiation Treatment for Breast. Cancer. Melissa James Radiation Oncologist August 2015
Radiation Treatment for Breast Cancer Melissa James Radiation Oncologist August 2015 OUTLINE External Beam Radiation treatment. (What is Radiation, doctor?) Role of radiation. (Why am I getting radiation,
More informationNCIC CLINICAL TRIALS GROUP DATA SAFETY MONITORING COMMITTEE Fall Conference Call 23 November 2009 SUMMARY REPORT
NCIC CLINICAL TRIALS GROUP DATA SAFETY MONITORING COMMITTEE Fall Conference Call 23 November 2009 SUMMARY REPORT The NCIC CTG DSMC reviewed the following trials with respect to safety, trial conduct, including
More informationFROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017
FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE Geoffrey S. Ibbott, Ph.D. June 20, 2017 1 DISCLOSURES My institution holds Strategic Partnership Research Agreements with Varian, Elekta, and Philips
More informationFlattening Filter Free beam
Dose rate effect in external radiotherapy: biology and clinic Marta Scorsetti, M.D. Radiotherapy and Radiosurgery Dep., Istituto Clinico Humanitas, Milan, Italy Brescia October 8th/9th, 2015 Flattening
More informationWhere are we with radiotherapy for biliary tract cancers?
Where are we with radiotherapy for biliary tract cancers? Professor Maria A. Hawkins Associate Professor in Clinical Oncology MRC Group Leader/Honorary Consultant Clinical Oncologist CRUK MRC Oxford Institute
More information:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B
04-10-2019 12:00-13:00 Industry Satellite Symposium 1 Room A 13:00-13:30 Welcome reception Hall 1 13:30-13:45 Opening and welcome Room B 13:45-14:15 HHH Award lecture Room B 13:45-14:15 HHH Award lecture
More informationCHEMO-RADIOTHERAPY FOR BLADDER CANCER. Dr Darren Mitchell Consultant Clinical Oncologist Northern Ireland Cancer Centre
CHEMO-RADIOTHERAPY FOR BLADDER CANCER Dr Darren Mitchell Consultant Clinical Oncologist Northern Ireland Cancer Centre AIMS Muscle invasive disease Current Gold-Standard Rationale behind Chemo-Radiotherapy
More informationCombining chemotherapy and radiotherapy of the chest
How to combine chemotherapy, targeted agents and radiotherapy in locally advanced NSCLC? Dirk De Ruysscher, MD, PhD Radiation Oncologist Professor of Radiation Oncology Leuven Cancer Institute Department
More informationRadiotherapy Physics and Equipment
Radiological Sciences Department Radiotherapy Physics and Equipment RAD 481 Lecture s Title: Introduction Dr. Mohammed EMAM Ph.D., Paris-Sud 11 University Vision :IMC aspires to be a leader in applied
More informationAdjuvant and Salvage Radiation for Prostate Cancer. Savita Dandapani, MD, PhD
Adjuvant and Salvage Radiation for Prostate Cancer Savita Dandapani, MD, PhD DISCLOSURES I am a consultant for Reflexion, receive funding from Bayer, and on the Speaker s Bureau with Astra Zeneca. Post-prostatectomy
More informationGuidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer
Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group
More informationManagement of metastatic squamous cell carcinoma cervical lymphadenopathy with occult primary The role of surgery
Management of metastatic squamous cell carcinoma cervical lymphadenopathy with occult primary The role of surgery Dr Gary Fetter General surgeon Waterfall City Hospital Midrand Excalibur II Garable Lector
More informationGamma Knife Radiosurgery A tool for treating intracranial conditions. CNSA Annual Congress 2016 Radiation Oncology Pre-congress Workshop
Gamma Knife Radiosurgery A tool for treating intracranial conditions CNSA Annual Congress 2016 Radiation Oncology Pre-congress Workshop ANGELA McBEAN Gamma Knife CNC State-wide Care Coordinator Gamma Knife
More informationAustralian Organisation Launches Large International Clinical Trials in Prostate Cancer
Australian Organisation Launches Large International Clinical Trials in Prostate Cancer Media Release Sydney 8 April, 2014: The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials
More informationThe Clinical Research E-News
The Clinical Research E-News Volume 3: ISSUE 16: September 28, 2011 Jefferson Kimmel Cancer Network: For urgent clinical trial questions or assistance please page: 877-656-9004 Now Open: C70604, A Randomized,
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND
More informationInnovation in radiotherapy: How to prove its value for money?
Innovation in radiotherapy: How to prove its value for money? Yolande Lievens, MD, PhD Radiation Oncology Ghent University Hospital & Ghent University, Belgium Co-Chair ESTRO-HERO project ESTRO President
More informationProstate Cancer Screening Where are we? Prof. Bob Steele Professor of Surgery, University of Dundee Independent Chair, UK NSC
Prostate Cancer Screening Where are we? Prof. Bob Steele Professor of Surgery, University of Dundee Independent Chair, UK NSC 1990 Screening The detection of disease in asymptomatic people in order to
More informationCLINICAL TRIALS Open clinical uro-oncology trials in Canada George Rodrigues, MD, Eric Winquist, MD
Open clinical uro-oncology trials in Canada George Rodrigues, MD, Eric Winquist, MD London Health Sciences Centre, London, Ontario, Canada bladder cancer AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE II
More informationMacmillan Publications
S1 S2 S3 S3 S3 S4 S5 S6 S7 S8 S8 S9 S10 S11 S11 S12 S13 S14 S15 S17 S18 S19 Bladder Cancer: Non-Invasive, Invasive and Advanced Bone Cancer: Primary, Secondary Colon Cancer, Anal Cancer, Rectal Cancer
More informationRADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS. Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1.
RADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1. 550 000 NEW PATIENTS/YEAR WITH HEAD AND NECK CANCER ALL
More information肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部
肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部 Outline Current status of radiation oncology in lung cancer Focused on stage III non-small cell lung cancer Radiation
More informationTranslational Radiation Oncology, Physics & Supportive Care (TROP) Mark De Ridder, Wim Distelmans & Dirk Verellen
Translational Radiation Oncology, Physics & Supportive Care (TROP) Mark De Ridder, Wim Distelmans & Dirk Verellen Tumor hypoxia: perfusion and diffusion limited oxygenation Hypoxia acute chronic 100 100
More informationX, Y and Z of Prostate Cancer
X, Y and Z of Prostate Cancer Dr Tony Michele Medical Oncologist Prostate cancer Epidemiology Current EUA (et al) guidelines on Advanced Prostate Cancer Current clinical management in specific scenarios
More informationProtocol of Radiotherapy for Breast Cancer
107 年 12 月修訂 Protocol of Radiotherapy for Breast Cancer Indication of radiotherapy Indications for Post-Mastectomy Radiotherapy (1) Axillary lymph node 4 positive (2) Axillary lymph node 1-3 positive:
More informationTrimodality Therapy for Muscle Invasive Bladder Cancer
Trimodality Therapy for Muscle Invasive Bladder Cancer Brita Danielson, MD, FRCPC Radiation Oncologist, Cross Cancer Institute Assistant Professor, Department of Oncology University of Alberta Edmonton,
More informationTHE TARGET. News from the Department of Radiation Oncology
U T S O U T H W E S T E R N THE TARGET News from the Department of Radiation Oncology VOLUME 3, Spring 2012 Hippocampus-sparing trial of whole brain radiation seeks to preserve memory Beam arrangement
More informationOral Cavity Cancer Combined modality therapy
Oral Cavity Cancer Combined modality therapy Dr. Christos CHRISTOPOULOS Radiation Oncologist Head and Neck Cancers Centre Hospitalier Universitaire (C.H.U.) de Limoges, France Disclosure slide I have no
More informationHALF. Who gets radiotherapy? Who gets radiotherapy? Half of all cancer patients get radiotherapy. By 1899 X rays were being used for cancer therapy
The Physical and Biological Basis of By 1899 X rays were being used for cancer therapy David J. Brenner, PhD, DSc Center for Radiological Research Department of Radiation Oncology Columbia University Medical
More informationEORTC LUNG CANCER GROUP GROUP MEETING
Sunday 7 th October 2018 Time slot Topic / Title of presentation Chair 9.00 11.00 Board meeting 11.00 11.30 Arrivals & Welcome coffee 11.30 11.50 Welcome & Introduction New Board,, Membership status, Calendar
More informationSubject Index. Androgen antiandrogen therapy, see Hormone ablation therapy, prostate cancer synthesis and metabolism 49
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Subject Index Androgen antiandrogen therapy, see Hormone ablation therapy, synthesis and metabolism 49 Bacillus Calmette-Guérin adjunct therapy with transurethral resection
More information4D Radiotherapy in early ca Lung. Prof. Manoj Gupta Dept of Radiotherapy & oncology I.G.Medical College Shimla
4D Radiotherapy in early ca Lung Prof. Manoj Gupta Dept of Radiotherapy & oncology I.G.Medical College Shimla Presentation focus on ---- Limitation of Conventional RT Why Interest in early lung cancer
More informationPLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, Steamboat Springs, Colorado. January 12-15, 2018
PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, 2018 16 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 12-15, 2018 Friday, January 12, 2018 Registration:
More informationManaging Prostate Cancer After Initital Treatment Fails: Are There Good Next Steps?
Managing Prostate Cancer After Initital Treatment Fails: Are There Good Next Steps? Michael J Zelefsky, M.D. Professor of Radiation Oncology Chief Brachytherapy Service Department of Radiation Oncology
More informationHigh-precision Radiotherapy
High-precision Radiotherapy a report by Professor Cai Grau and Dr Morten Hoyer Department of Oncology, Aarhus University Hospital, Denmark DOI: 10.17925/EOH.2005.0.0.40 Professor Cai Grau Dr Morten Hoyer
More informationFuture of Radiation Therapy
Future of Radiation Therapy JP Morgan Healthcare Conference January 12, 2016 Deepak Khuntia, MD, VP of Medical Affairs Patrick Kupelian, MD, VP of Clinical Affairs Cancer as a cause of death CANCER TREATMENT
More informationNEOADJUVANT THERAPY IN CARCINOMA STOMACH. Dr Jyotirup Goswami Consultant Radiation Oncologist Narayana Superspeciality Hospital, Howrah
NEOADJUVANT THERAPY IN CARCINOMA STOMACH Dr Jyotirup Goswami Consultant Radiation Oncologist Narayana Superspeciality Hospital, Howrah NEOADJUVANT THERAPY?! Few believers Limited evidence Many surgeons
More informationDisclosures. Overview 8/3/2016. SRS: Cranial and Spine
SRS: Cranial and Spine Brian Winey, Ph.D. Department of Radiation Oncology Massachusetts General Hospital Harvard Medical School Disclosures Travel and research funds from Elekta Travel funds from IBA
More informationANNUAL RESEARCH REPORT 2012
ANNUAL RESEARCH REPORT 2012 ANNUAL RESEARCH REPORT 02 CONTENTS 01. Review of Operations President s Report Scientific Committee Chair s Report TROG Central Operations Office Report Central Quality Assurance
More informationRadiotherapy for Rectal Cancer. Kevin Palumbo Adelaide Radiotherapy Centre
Radiotherapy for Rectal Cancer Kevin Palumbo Adelaide Radiotherapy Centre Overview CRC are common (3 rd commonest cancer) rectal Ca approx 25-30% of all CRC. Presentation PR bleeding: beware attributing
More informationSCIENTIFIC PROGRAMME SNOLA UPDATE ON NEURO- ONCOLOGY th March
SCIENTIFIC PROGRAMME SNOLA UPDATE ON NEURO- ONCOLOGY 2016 24th March 13h 13h45 pathology case case parasellar meningeoma case : posterior fossa pediatric tumor 13h45 16h Imaging for CNS lymphomas Parasellar
More informationOpen clinical uro-oncology trials in Canada
CLINICAL TRIALS Open clinical uro-oncology trials in Canada Eric Winquist, MD, Mary J. Mackenzie, MD, George Rodrigues, MD London Health Sciences Centre, London, Ontario, Canada ADRENOCORTICAL MALIGNANCIES
More informationDe-Escalate Trial for the Head and neck NSSG. Dr Eleanor Aynsley Consultant Clinical Oncologist
De-Escalate Trial for the Head and neck NSSG Dr Eleanor Aynsley Consultant Clinical Oncologist 3 HPV+ H&N A distinct disease entity Leemans et al., Nature Reviews, 2011 4 Good news Improved response to
More informationBreast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined
Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases
More informationStereotactic radiotherapy
Stereotactic radiotherapy Influence of patient positioning and fixation on treatment planning - clinical results Frank Zimmermann Institut für Radioonkologie Universitätsspital Basel Petersgraben 4 CH
More informationOpen clinical uro-oncology trials in Canada Eric Winquist, MD, George Rodrigues, MD
Open clinical uro-oncology trials in Canada Eric Winquist, MD, George Rodrigues, MD London Health Sciences Centre, London, Ontario, Canada BLADDER CANCER A MULTICENTRE, RANDOMIZED PLACEBO-CONTROLLED, DOUBLE-BLIND
More informationBreast Cancer. Saima Saeed MD
Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast
More informationSCOTTISH ONCOLOGY SUMMIT Double Tree by Hilton, Dunblane Hydro, Dunblane 1 st - 2 nd September 2017
Friday 1 st September 1300h 1400h Lunch (arrival, registration at conference foyer, coffee and sponsors exhibition) 1400h 1420h Prof Robert Jones Welcome/Announcements 1430h 1600h Parallel sessions: Lung
More informationIORT What We ve Learned So Far
IORT What We ve Learned So Far The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging Einsley-Marie Janowski, MD, PhD Assistant Professor Department of Radiation
More informationANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:
1 ANNEX 1 OBJECTIVES At the completion of the training period, the fellow should be able to: 1. Breast Surgery Evaluate and manage common benign and malignant breast conditions. Assess the indications
More informationEtudes cliniques Service d Oncologie - Radiothérapie
Etudes cliniques Service d Oncologie - Radiothérapie Décembre 2017 SEIN NEO ADJUVANT WO39392 (Impassion 031) : A phase III randomized study to investigate the efficacy and safety of Atezolizumab in combination
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org Conservative Treatment of Invasive Bladder Cancer Luis Souhami, MD Professor Department of Radiation Oncology
More informationEducational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery
Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery Goal The goal of the Breast Surgery rotation is to develop the knowledge, skills and attitudes necessary to evaluate,
More informationConcomitant (without adjuvant) temozolomide and radiation to treat glioblastoma: A retrospective study
Concomitant (without adjuvant) temozolomide and radiation to treat glioblastoma: A retrospective study T Sridhar 1, A Gore 1, I Boiangiu 1, D Machin 2, R P Symonds 3 1. Department of Oncology, Leicester
More informationRADIOTHERAPY- CURRENT SITUATION AND FUTURE TRENDS
HOSPITAL OF LITHUANIAN UNIVERSITY OF HEALTH SCIENCES KAUNO KLINIKOS RADIOTHERAPY- CURRENT SITUATION AND FUTURE TRENDS Prof. Elona Juozaitytė Perspectives of Czech- Lithuanian Research Partnerships About
More informationREVIEW ARTICLE. Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer
REVIEW ARTICLE Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer Kate Haslett 1, Christoph Pöttgen 2, Martin Stuschke 2, Corinne Faivre-Finn 1,3 1 Radiotherapy Related Research,
More informationMUSCLE - INVASIVE AND METASTATIC BLADDER CANCER
10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg
More informationACR TXIT TM EXAM OUTLINE
ACR TXIT TM EXAM OUTLINE Major Domain Sub-Domain 1 Statistics 1.1 Study design 1.2 Definitions of statistical terms 1.3 General interpretation & analysis 1.4 Survival curves 1.5 Specificity/sensitivity
More informationEnterprise Interest None
Enterprise Interest None Cervical Cancer -Management of late stages ESP meeting Bilbao Spain 2018 Dr Mary McCormack PhD FRCR Consultant Clinical Oncologist University College Hospital London On behalf
More informationOpen clinical uro-oncology trials in Canada George Rodrigues, MD, Mary J. Mackenzie, MD, Eric Winquist, MD
Open clinical uro-oncology trials in Canada George Rodrigues, MD, Mary J. Mackenzie, MD, Eric Winquist, MD London Health Sciences Centre, London, Ontario, Canada BLADDER CANCER A MULTICENTRE, RANDOMIZED
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM BRAIN METASTASES CNS Site Group Brain Metastases Author: Dr. Norm Laperriere Date: February 20, 2018 1. INTRODUCTION
More informationFaster Cancer Treatment Indicators: Use cases
Faster Cancer Treatment Indicators: Use cases 2014 Date: October 2014 Version: Owner: Status: v01 Ministry of Health Cancer Services Final Citation: Ministry of Health. 2014. Faster Cancer Treatment Indicators:
More informationClinical Management Guideline for Planning and Treatment. The process to be followed when a course of chemotherapy is required to treat:
Clinical Management Guideline for Planning and Treatment The process to be followed when a course of chemotherapy is required to treat: PROSTATE CANCER Patient information given at each stage following
More informationSteamboat Springs, Colorado. January 15-18, 2016
Friday, January 15, 2016 Registration: Begins at 2:00 pm Plenary Session: 4:00 pm - 6:00 pm 14 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 15-18, 2016 Current Status
More informationGuideline for the Management of Vulval Cancer
Version History Guideline for the Management of Vulval Cancer Version Date Brief Summary of Change Issued 2.0 20.02.08 Endorsed by the Governance Committee 2.1 19.11.10 Circulated at NSSG meeting 2.2 13.04.11
More informationOpen clinical uro-oncology trials in Canada Eric Winquist, MD, George Rodrigues, MD
CLINICAL TRIALS Open clinical uro-oncology trials in Canada Eric Winquist, MD, George Rodrigues, MD London Health Sciences Centre, London, Ontario, Canada bladder cancer A PHASE II PROTOCOL FOR PATIENTS
More informationTHE TARGET. New radiation oncology facility showcases latest technology. News from the Department of Radiation Oncology.
U T S O U T H W E S T E R N THE TARGET News from the Department of Radiation Oncology VOLUME 2, WINTER 2011 2012 New radiation oncology facility showcases latest technology Harold C. Simmons Comprehensive
More informationIntensity Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) Policy Number: Original Effective Date: MM.05.006 03/09/2004 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 05/01/2017 Section: Radiology
More information17. Oesophagus. Upper gastrointestinal cancer
110 17. Upper gastrointestinal cancer Oesophagus Radical treatment For patients with localised disease, the standard curative approach to treatment is either surgery + perioperative chemotherapy, surgery
More informationProton Therapy: Where Are We Now and Where Are We Going? Erin Davis MSN, CRNP, ACNP BC Lead Nurse Practitioner
Proton Therapy: Where Are We Now and Where Are We Going? Erin Davis MSN, CRNP, ACNP BC Lead Nurse Practitioner Genevieve Hollis MSN, CRNP, ANP-BC, AOCN Oncology Nurse Practitioner Advanced Senior Lecturer-B
More informationOpen clinical uro-oncology trials in Canada
Open clinical uro-oncology trials in Canada Eric Winquist, MD, George Rodrigues, MD London Health Sciences Centre, London, Ontario, Canada bladder cancer A PHASE II PROTOCOL FOR PATIENTS WITH STAGE T1
More informationAdvances in external beam radiotherapy
International Conference on Modern Radiotherapy: Advances and Challenges in Radiation Protection of Patients Advances in external beam radiotherapy New techniques, new benefits and new risks Michael Brada
More informationPalliative radiotherapy in lung cancer
New concepts and insights regarding the role of radiation therapy in metastatic disease Umberto Ricardi University of Turin Department of Oncology Radiation Oncology Palliative radiotherapy in lung cancer
More informationLocally advanced disease & challenges in management
Gynecologic Cancer InterGroup Cervix Cancer Research Network Cervix Cancer Education Symposium, February 2018 Locally advanced disease & challenges in management Carien Creutzberg Radiation Oncology, Leiden
More information